U.S. flag

An official website of the United States government

NM_001165963.4(SCN1A):c.5347G>A (p.Ala1783Thr) AND Generalized epilepsy with febrile seizures plus, type 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 5, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001849308.11

Allele description [Variation Report for NM_001165963.4(SCN1A):c.5347G>A (p.Ala1783Thr)]

NM_001165963.4(SCN1A):c.5347G>A (p.Ala1783Thr)

Genes:
SCN1A:sodium voltage-gated channel alpha subunit 1 [Gene - OMIM - HGNC]
LOC102724058:uncharacterized LOC102724058 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
2q24.3
Genomic location:
Preferred name:
NM_001165963.4(SCN1A):c.5347G>A (p.Ala1783Thr)
Other names:
p.A1783T:GCG>ACG
HGVS:
  • NC_000002.12:g.165991928C>T
  • NG_011906.1:g.86712G>A
  • NM_001165963.4:c.5347G>AMANE SELECT
  • NM_001165964.3:c.5263G>A
  • NM_001202435.3:c.5347G>A
  • NM_001353948.2:c.5347G>A
  • NM_001353949.2:c.5314G>A
  • NM_001353950.2:c.5314G>A
  • NM_001353951.2:c.5314G>A
  • NM_001353952.2:c.5314G>A
  • NM_001353954.2:c.5311G>A
  • NM_001353955.2:c.5311G>A
  • NM_001353957.2:c.5263G>A
  • NM_001353958.2:c.5263G>A
  • NM_001353960.2:c.5260G>A
  • NM_001353961.2:c.2905G>A
  • NM_006920.6:c.5314G>A
  • NP_001159435.1:p.Ala1783Thr
  • NP_001159435.1:p.Ala1783Thr
  • NP_001159436.1:p.Ala1755Thr
  • NP_001189364.1:p.Ala1783Thr
  • NP_001340877.1:p.Ala1783Thr
  • NP_001340878.1:p.Ala1772Thr
  • NP_001340879.1:p.Ala1772Thr
  • NP_001340880.1:p.Ala1772Thr
  • NP_001340881.1:p.Ala1772Thr
  • NP_001340883.1:p.Ala1771Thr
  • NP_001340884.1:p.Ala1771Thr
  • NP_001340886.1:p.Ala1755Thr
  • NP_001340887.1:p.Ala1755Thr
  • NP_001340889.1:p.Ala1754Thr
  • NP_001340890.1:p.Ala969Thr
  • NP_008851.3:p.Ala1772Thr
  • LRG_8t1:c.5314G>A
  • LRG_8:g.86712G>A
  • NC_000002.11:g.166848438C>T
  • NM_001165963.1:c.5347G>A
  • NM_001165963.2:c.5347G>A
  • NM_006920.4:c.5314G>A
  • NR_148667.2:n.5764G>A
Protein change:
A1754T
Links:
UniProtKB/Swiss-Prot: VAR_064275; dbSNP: rs121917980
NCBI 1000 Genomes Browser:
rs121917980
Molecular consequence:
  • NM_001165963.4:c.5347G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165964.3:c.5263G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001202435.3:c.5347G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353948.2:c.5347G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353949.2:c.5314G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353950.2:c.5314G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353951.2:c.5314G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353952.2:c.5314G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353954.2:c.5311G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353955.2:c.5311G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353957.2:c.5263G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353958.2:c.5263G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353960.2:c.5260G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353961.2:c.2905G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006920.6:c.5314G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148667.2:n.5764G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Generalized epilepsy with febrile seizures plus, type 2 (GEFSP2)
Synonyms:
GEFS+, TYPE 2
Identifiers:
MONDO: MONDO:0011461; MedGen: C1858673; Orphanet: 36387; OMIM: 604403

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002107108DASA
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 5, 2022)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Dravet syndrome in South African infants: Tools for an early diagnosis.

Esterhuizen AI, Mefford HC, Ramesar RS, Wang S, Carvill GL, Wilmshurst JM.

Seizure. 2018 Nov;62:99-105. doi: 10.1016/j.seizure.2018.09.010. Epub 2018 Sep 14.

PubMed [citation]
PMID:
30321769
PMCID:
PMC6261486

Early clinical features in Dravet syndrome patients with and without SCN1A mutations.

Petrelli C, Passamonti C, Cesaroni E, Mei D, Guerrini R, Zamponi N, Provinciali L.

Epilepsy Res. 2012 Mar;99(1-2):21-7. doi: 10.1016/j.eplepsyres.2011.10.010. Epub 2011 Nov 8.

PubMed [citation]
PMID:
22071555
See all PubMed Citations (6)

Details of each submission

From DASA, SCV002107108.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (6)

Description

The c.5347G>A;p.(Ala1783Thr) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 68570; PMID: 30321769; PMID: 26096185; PMID: 17347258; PMID: 22071555; PMID: 19589774) - PS4. The variant is located in a mutational hot spot and/or critical and well-established functional domain (Ion_trans;PKD_channel) - PM1. This variant is not present in population databases (rs121917980- gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. Pathogenic missense variant in this residue have been reported (ClinVar ID: 68571) - PM5. The variant was assumed de novo, but without confirmation of paternity and maternity (PMID: 17347258) - PM6. The variant co-segregated with disease in multiple affected family members (PMID: 26096185) - PP1. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Apr 20, 2024